Literature DB >> 22750971

New-onset diabetes with a history of dyslipidemia predicts pancreatic cancer.

Chin-Hsiao Tseng1.   

Abstract

OBJECTIVE: This study aimed to investigate whether the reported relationship between diabetes and pancreatic cancer (PC) could result from detection bias and whether dyslipidemia and/or new-onset diabetes (diagnosed within 1 year) could predict PC.
METHODS: A random sample of 1 million subjects covered by National Health Insurance was recruited. From 2003 to 2005, 495,493 men and 503,901 women without PC were followed up. Cox regression was used to evaluate the adjusted relative risk considering potential PC detection examinations and covariates.
RESULTS: Diabetic patients had a significantly higher probability of receiving examinations that might lead to PC diagnosis. In Cox proportional hazards regression models, diabetes was not a significant predictor, but dyslipidemia was significantly associated with an approximately 40% higher risk of PC. Age, living in more urbanized regions, and potential PC detection examinations were significant covariates. Patients with new-onset diabetes and previous dyslipidemia had a remarkably higher risk compared with those without either condition (relative risk [95% confidence interval], 2.512 [1.169-5.398]).
CONCLUSIONS: Dyslipidemia, but not diabetes, is a significant risk factor for PC. The link between diabetes and PC is likely due to confounders and detection bias. Patients with new-onset diabetes and a history of dyslipidemia are at an especially high risk of PC.

Entities:  

Mesh:

Year:  2013        PMID: 22750971     DOI: 10.1097/MPA.0b013e3182571ba9

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  12 in total

Review 1.  Diabetes and gastric cancer: the potential links.

Authors:  Chin-Hsiao Tseng; Farn-Hsuan Tseng
Journal:  World J Gastroenterol       Date:  2014-02-21       Impact factor: 5.742

2.  Rosiglitazone may reduce non-melanoma skin cancer risk in Taiwanese.

Authors:  Chin-Hsiao Tseng
Journal:  BMC Cancer       Date:  2015-02-06       Impact factor: 4.430

3.  Type 2 diabetes mellitus is more prevalent among patients with thyroid carcinoma and influences overall survival: a propensity score matching analysis.

Authors:  Tao Jiang; Guoliang Qiao; Xiao Zheng; Zhen Wen; Dongxue Zhang
Journal:  Oncotarget       Date:  2017-10-31

4.  Type 2 diabetes mellitus is associated with increased risk of pancreatic cancer: A veteran administration registry study.

Authors:  Issam Makhoul; Abdulraheem Yacoub; Eric Siegel
Journal:  SAGE Open Med       Date:  2016-12-14

5.  Development of a prediction model for pancreatic cancer in patients with type 2 diabetes using logistic regression and artificial neural network models.

Authors:  Meng Hsuen Hsieh; Li-Min Sun; Cheng-Li Lin; Meng-Ju Hsieh; Chung-Y Hsu; Chia-Hung Kao
Journal:  Cancer Manag Res       Date:  2018-11-26       Impact factor: 3.989

Review 6.  The bidirectional interation between pancreatic cancer and diabetes.

Authors:  Junhui Li; Gang Cao; Qingyong Ma; Han Liu; Wei Li; Liang Han
Journal:  World J Surg Oncol       Date:  2012-08-24       Impact factor: 2.754

7.  Diabetes and cancer: epidemiological, clinical, and experimental perspectives.

Authors:  Chin-Hsiao Tseng; Chien-Jen Chen; Joseph R Landolph
Journal:  Exp Diabetes Res       Date:  2012-10-02

8.  Diabetes but not insulin increases the risk of lung cancer: a Taiwanese population-based study.

Authors:  Chin-Hsiao Tseng
Journal:  PLoS One       Date:  2014-07-03       Impact factor: 3.240

9.  Human insulin does not increase bladder cancer risk.

Authors:  Chin-Hsiao Tseng
Journal:  PLoS One       Date:  2014-01-20       Impact factor: 3.240

10.  Metformin reduces thyroid cancer risk in Taiwanese patients with type 2 diabetes.

Authors:  Chin-Hsiao Tseng
Journal:  PLoS One       Date:  2014-10-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.